Company · CIK 1609809
Seres Therapeutics, Inc.
| CIK | 1609809 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | MCRB (Nasdaq) |
| First annual or quarterly report | 2015-08-10 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298309 | 2026-08-13 | 2026-08-21 | 2 | |
| 333-273794 | 2023-08-08 | 2026-08-04 | 3 | |
| 333-282450 | 2024-10-01 | 2024-10-11 | 2 | |
| 333-244401 | 2020-08-11 | 2022-06-30 | 6 | |
| 333-237033 | 2020-03-09 | 2020-08-14 | 4 | |
| 333-216735 | 2017-03-16 | 2019-11-27 | 5 | |
| 333-204484 | 2015-05-27 | 2015-06-26 | 5 |
Filings
28| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-21 | EFFECTDeclared effective | 333-298309 | 9999999995-26-002733 |
| 2026-08-13 | S-3Shelf registered | 333-298309 | 0001193125-26-349330 |
| 2026-08-04 | 424B5Shelf takedown | 333-273794 | 0001193125-26-332730 |
| 2024-10-11 | EFFECTDeclared effective | 333-282450 | 9999999995-24-003174 |
| 2024-10-01 | S-3Shelf registered | 333-282450 | 0001193125-24-230253 |
| 2023-08-15 | EFFECTDeclared effective | 333-273794 | 9999999995-23-002400 |
| 2023-08-08 | S-3Shelf registered | 333-273794 | 0001193125-23-206199 |
| 2022-06-30 | 424B5Shelf takedown | 333-244401 | 0001193125-22-185602 |
| 2022-05-06 | EFFECTDeclared effective | 333-244401 | 9999999995-22-001340 |
| 2021-05-21 | 424B5Shelf takedown | 333-244401 | 0001193125-21-169353 |
| 2020-08-14 | 424B5Shelf takedown | 333-237033 | 0001193125-20-220574 |
| 2020-08-14 | 424B5Shelf takedown | 333-244401 | 0001193125-20-220573 |
| 2020-08-11 | 424B5Shelf takedown | 333-244401 | 0001193125-20-216509 |
| 2020-08-11 | S-3ASRShelf registered | 333-244401 | 0001193125-20-216465 |
| 2020-03-18 | EFFECTDeclared effective | 333-237033 | 9999999995-20-000587 |
| 2020-03-18 | 424B5Shelf takedown | 333-237033 | 0001193125-20-077200 |
| 2020-03-09 | S-3Shelf registered | 333-237033 | 0001193125-20-067187 |
| 2019-11-27 | 424B5Shelf takedown | 333-216735 | 0001193125-19-301823 |
| 2019-06-14 | 424B5Shelf takedown | 333-216735 | 0001193125-19-173661 |
| 2019-06-12 | 424B5Shelf takedown | 333-216735 | 0001193125-19-171388 |
| 2017-03-24 | EFFECTDeclared effective | 333-216735 | 9999999995-17-000670 |
| 2017-03-16 | S-3Shelf registered | 333-216735 | 0001193125-17-085007 |
| 2015-06-26 | 424B4Final prospectus | 333-204484 | 0001193125-15-236625 |
| 2015-06-25 | EFFECTDeclared effective | 333-204484 | 9999999995-15-001744 |
| 2015-06-24 | S-1/AAmendment | 333-204484 | 0001193125-15-233542 |
| 2015-06-16 | S-1/AAmendment | 333-204484 | 0001193125-15-224101 |
| 2015-05-27 | S-1Registration filed | 333-204484 | 0001193125-15-202059 |
| 2014-12-11 | DRSDraft made public | 377-00874 | 0000950123-14-012678 |